localized to the new leading pole after a 10-s delay. Thus, AglZ may not trigger polar switching, but rather might be assembled at the new leading pole along with other motility components.
The Frz chemosensory pathway, which regulates cell reversals, controls FrzS translocation to the leading pole when cells reverse direction (4) . In a nonreversing frzE mutant, AglZ-YFP localization never switched poles. In contrast, a hyperreversing frzCD c mutant showed very frequent reversals that were always followed by AglZ-YFP polar switching (Fig. 3 , C and D, and table S2). In this frzCD c strain, AglZ-YFP was mostly polar in distribution, and ordered intracellular fluorescence clusters were only observed transiently. Thus, cellular reversals result from the concerted switching of both A-and S-motility components to the new leading pole (4) . Coordination of these two engines must be achieved through the signaling activity of a common pathway.
Although AglZ-YFP localized to transient adhesion sites, it is unclear whether the force that produces locomotion is generated at those sites. To address this question, we investigated the motility of cells treated with the antibiotic cephalexin. Cephalexin-treated cells, which elongate up to 10 times their natural length, showed almost normal A motility but greatly reduced S motility, which suggests that the A engine is distributed along the cell body whereas the S engine is polar (9) . We also observed that 10-to 30-mm-long A + S --motile cephalexin-treated cells moved with velocities that were independent of cell length. The localization of AglZ-YFP was also correlated with the activity of the A engine in these cells (Fig. 4A ). In these moving filaments, AglZ-YFP was localized in clusters that were distributed in the front part of the cell, whereas the back of the cell was largely depleted of clusters (Fig. 4A) ; consequently, the number of clusters per cell was largely independent of cell length (Fig. 4B) . Thus, in the filaments, we could test whether force was produced at the sites where AglZ-YFP accumulates by analyzing the relationship between the number of sites and the "drag force overcome" [i.e., the force necessary to power the motility of a cell of given cell length and velocity (5)]. Indeed, the drag force overcome was proportional to the number of clusters in filamentous cells (Fig. 4C) , indicating that motility force seems to be produced at the adhesion sites; these characteristics are similar to eukaryotic focal adhesions where both adhesion and force are generated (10) .
Previously, a "slime gun" model for gliding motility was proposed because, in several bacterial species, motility is correlated with the secretion of slime through pores (nozzles) located in the outer membrane (11, 12) , and a biophysical model suggested that the hydration of slime within the nozzles could generate sufficient force to propel bacteria forward (11) . Our results are consistent with an alternate model, whereby intracellular motor complexes that connect to both membranespanning adhesion complexes and to the cytoskeleton power motility by pushing against the substratum and moving the cell body forward, much like focal adhesion-based traction or apicomplexan gliding motility in eukaryotic organisms ( fig. S5) (10, 13) . The periodicity of the AglZ-YFP clusters strongly implies the existence of a continuous helical filament that spans the length of the cell. Thus, the action of the motor complexes may induce the cell body to rotate as it pulls the cell forward ( fig. S5) . Rotation of the cell body as cells move has been shown for Cytophaga sp., an organism that also secretes slime during motility (14) . Slime secretion may be part of the motility system, by supplying additional power for movement and/or adhesion or lubrication of the interface between the cell body and the substratum (10) . The dynamics of AglZ-YFP and FrzS-green fluorescent protein (GFP) fusion protein (4) suggest how the A and S engines might be coordinated: A and S complexes oscillate so that they are targeted together to the new leading pole upon cellular reversal, which is synchronized by the Frz chemosensory system. A widely embraced model for the initiation of apoptosis (4) (Fig. 1A) proposes that a subset of BH3-only proteins termed "activators"-namely Bim and Bid (4-6) and, perhaps, Puma (7)-directly engage Bax or Bak. The other BH3-only proteins, termed "sensitizers" (for example, Bad and Noxa), purportedly act only by displacing the activators from the pro-survival proteins, allowing the activators to bind Bax and Bak. An alternative indirect model (8, 9) (Fig. 1A) , supported here, posits that BH3-only proteins activate Bax or Bak not by binding either one but indirectly, by engaging the multiple pro-survival relatives that constrain them. In this scenario, Bim, Bid, and Puma are highly potent because they engage all pro-survival proteins, whereas the others are less so because they bind only selective subsets (8) .
We first investigated whether BH3 peptides associate with Bax in vitro (10) . The Bim and Bid S2 ). In non-ionic detergents that alter the Bax conformation ( fig. S3 ) (11) , perhaps mimicking an activation step, they did bind ( fig. S1A ). However, their affinities for Bax (in the micromolar range) (Fig. 1B) appeared to be lower than those (in the nanomolar range) for the prosurvival proteins (8) (fig. S1C ). Thus, Bim and Bid peptides bound weakly and only after Bax had changed conformation. No other BH3 peptide, including that of Puma, bound even to activated Bax (Fig. 1B) .
Coimmunoprecipitation studies extended these observations to full-length BH3-only proteins in cell lysates ( fig. S4) (10) . In lysates of human embryonic kidney 293T cells prepared with the detergent Triton X-100, BH3-only proteins bound to Bcl-2 or other pro-survival proteins (8) but not to endogenous Bak ( fig. S4) . Similarly, in lysates made with CHAPS, a detergent that maintains Bax as a soluble monomer (11) , no BH3-only protein bound Bax. In Triton X-100 lysates, Bax did bind detectably to the truncated Bid (tBid) produced by caspases, but not to full-length Bid ( fig. S4A ), which has its BH3 domain buried (12) . Bim EL and Bim L , the only Bim isoforms detectable in multiple cell types ( fig. S5 ), failed to bind Bax ( fig. S4B ) (13), though both killed cells efficiently (8) . Bax did bind the very minor Bim S isoform ( fig. S4B ) and some unusual Bim variants confined to certain primates ( fig. S6 ). However, no Bax was detectable in endogenous Bim protein complexes (Fig. 1C) , even those from mouse thymocytes treated with ionomycin, which kills via a Bimdependent pathway (14) . In contrast, the binding of Bim to endogenous pro-survival proteins was evident, and this binding increased after cellular insults (Fig. 1C) (15, 16) . Thus, Bim did not form physiologically relevant complexes with Bax or Bak.
To test whether cell killing by tBid or Bim S requires their binding to Bax, we used a mutation, glycine to alanine [Gly 94 → Ala 94 (G94A)], within their BH3 domains that abrogated binding to Bax but not to the pro-survival proteins (Fig. 2 and figs. S7 to S9). Despite its inability to bind Bax, tBid G94A killed mouse embryo fibroblasts (MEFs) and mouse myeloid cells as effectively as the wild-type protein, in both short-term viability (figs. S7 and S9) and clonogenic (Fig.  2B) assays. Our studies with MEFs lacking Bax or Bak ( fig. S9 ) showed that either Bak or Bax could mediate the killing. Furthermore, the Bid G94A BH3 peptide, like the wild-type peptide, promoted cytochrome c release from mitochondria in vitro (Fig. 2C) (10) . The equivalent Bim S mutant gave similar results (figs. S8 and S9).
Thus, tBid and Bim can induce apoptosis without binding Bax or Bak. We inferred that these proteins and their G-to-A mutants caused cell death by binding to and neutralizing diverse (8, 10) . IC 50 , median inhibitory concentration. NB, no binding at 10 mM. (C) Coimmunoprecipitation tests in Triton X-100-containing lysates of healthy thymocytes (-) or 24 hours after treatment with ionomycin (+), a Bimdependent stimulus (14) . Bim-containing complexes, isolated using an antibody (3C5) that recognizes all Bim isoforms, were examined for Bax, Bcl-2, or Mcl-1 (upper three panels). Control, isotype-matched antibody immunoprecipitation; WCL, whole-cell lysates; IP, immunoprecipitation. pro-survival proteins (8) . Indeed, the corresponding glycine-to-glutamate mutants, which do not bind most (or any) pro-survival family members, did not kill (Fig. 2 and figs. S7 to S9) .
If Bim and Bid [the major candidate activator BH3-only proteins (4-6)] were essential for apoptosis, as the direct-activation model implies, mice lacking both proteins (10) should exhibit developmental abnormalities, like Bax-Bakdeficient animals, which usually die as neonates (2) . Instead, mice lacking both Bim and Bid were born at the expected Mendelian frequency ( fig.  S10 ), appeared normal (e.g., no webbing between the toes), and remained healthy for over 12 months. Moreover, comparison of the sensitivity to DNA damage of immortalized MEFs from Bim-Bid double-knockout (DKO), wild-type, or Bax-Bak DKO embryos ( fig. S11) revealed that, whereas Bax-Bak deficiency conferred resistance to ultraviolet (UV) irradiation and etoposide, the absence of both Bim and Bid neither abrogated apoptosis nor prevented Bax activation (Fig. 3, A and B) .
Because the direct-activation model (Fig. 1A ) proposes that only an activator BH3-only protein can kill cells, we tested whether the sensitizers Bad and Noxa (4) could kill cells lacking both Bim and Bid. Although overexpression of Bad and Noxa together killed wild-type MEFs (8) and neither bound Bax or Bak (Fig. 1B and fig.  S4C ), we could not exclude the possibility that they killed by displacing endogenous Bim or tBid. However, even in the absence of both Bim and Bid, the Noxa-Bad combination (Fig. 3, C Although one study reported that Puma bound Bax (7), its putative activator role is disputed (5, 6). We and others (18) have detected no association of Puma with Bax or Bak (Fig. 1B  and fig. S4C ). Nevertheless, to assess whether Puma has any role as an activator, we decreased Puma expression with RNA interference in bim S14 ). As expected (19) , its reduction impaired etoposide-induced death. Nevertheless, in cells retaining only a small amount of Puma and no Bim or Bid, the Noxa-ABT-737 combination still efficiently provoked apoptosis and cytochrome c release ( fig. S14) .
We conclude that BH3-only proteins can initiate apoptosis without binding Bax or Bak, although the cooperativity with Bax of tBid (or of a stapled Bid BH3 peptide) in lysing protein-free liposomes (5, 20, 21) may indicate that direct activation contributes under some circumstances. We (8, 9) and others (22) have suggested that all BH3-only proteins function by engaging their pro-survival relatives and overcoming their block to Bax or Bak activation (Fig. 1A) . Mcl-1 and Bcl-x L (but not Bcl-2) can constrain Bak by sequestering it, because enforced coexpression of Bad (to target Bcl-x L ) and Noxa (to target Mcl-1) elicited Bak-dependent apoptosis without any additional stimulus (9) .
Which of the multiple pro-survival proteins that can bind Bax ( fig. S15A) (Fig. 4A) , which inactivates Bcl-2, Bcl-x L , and Bcl-w (17) . To identify other pro-survival antagonists of Bax (10), we used Noxa mutant m3, which binds Mcl-1, Bcl-x L , and Bcl-w, but not Bcl-2 (8) (Fig. 4B) . It kills cells expressing only Bak (9), but not Bax-expressing ones (i.e., Bak KO cells) (Fig. 4B) . Because Noxa m3 spares Bcl-2, Bcl-2 is implicated as another check on Bax. We tested this hypothesis using a functional Bax mutant [Lys . S15B ). The ability of Noxa m3 to kill MEFs that express K64A but not wild-type Bax (Fig. 4C) confirms that Bcl-2 can prevent Bax activation. Hence, Bax is held in check by Mcl-1, Bcl-2, and either Bcl-x L or Bcl-w, or by all four (Fig. 4D) . Genetically, both Bcl-2 and Bcl-x L can constrain Bax, because its concomitant loss precludes the lymphoid hypoplasia (23) or neuronal apoptosis (24) caused by their respective deficiencies. Thus, whereas only certain pro-survival proteins keep Bak in check (9) , all of these proteins probably inhibit Bax (Fig. 4D) . Presumably, they bind a "primed" conformer of Bak or Bax-a form that may normally be present at low levels or may be formed early in apoptotic signaling.
Our findings emphasize that the central role of the mammalian pro-survival Bcl-2 proteins, like their virally encoded orthologs (25) , is to inhibit Bax and Bak (Fig. 4D) (8, 9) . Thus, BH3-only proteins trigger apoptosis indirectly through Bax or Bak by neutralizing all of the relevant prosurvival proteins, allowing the activation of Bax and Bak to proceed.
